FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2955194530> ?p ?o ?g. }

• W2955194530 endingPage "669" @default.
• W2955194530 startingPage "663" @default.
• W2955194530 abstract "Abstract OBJECTIVE To evaluate effects of poly(ADP-ribose) polymerase-1 (PARP1) inhibitors on the production of tumor necrosis factor-α (TNF-α) by interferon-γ (IFN-γ)– and lipopolysaccharide (LPS)-stimulated peripheral blood mononuclear cells (PBMCs) of horses as an in vitro model of inflammation in horses. SAMPLE 1,440 samples of PBMCs from 6 healthy research horses. PROCEDURES From heparinized whole blood samples, PBMC cultures were obtained. An initial dose-response trial on 48 PBMC samples from 2 horses (24 samples each) was used to determine concentrations of IFN-γ and LPS for use as low- and high-level stimulation concentrations. Seventy-two PBMC samples from 6 horses were assigned equally to 1 of 4 PARP1 inhibition categories: no PARP1 inhibitor (PARP1 inhibition control); 2-(( R )-2-methylpyrrolidin-2-yl)-1 H -benzimidazole-4-carbozamide dihydrochloride (ABT888);4-(3-(1-(cyclopropanecarbonyl)piperazine-4-carbonyl)-4-fluorobenzyl)phthalazin-1(2 H )-one (AZD2281); or N -(6-oxo-5,6-dihydrophenanthridin-2-yl) - N,N -dimethylacetamide hydrochloride (PJ34). Samples of PBMCs from each horse and each PARP1 inhibition category were then assigned to 1 of 3 levels of IFN-γ and LPS stimulation: none (control), low stimulation, or high stimulation. After a 24-hour incubation period, a TNF-α ELISA was used to measure TNF-α concentration in the supernatant. Results were compared across treatments and for each horse. Data were analyzed with repeated-measures ANOVA. RESULTS Median TNF-α concentration was significantly lower for PJ34-treated, high-level stimulated PBMCs than for PARP1 inhibition control, high-level stimulated PBMCs; however, no other meaningful differences in TNF-α concentration were detected among the inhibition and stimulation combinations. CONCLUSIONS AND CLINICAL RELEVANCE Findings suggested that PJ34 PARP1 inhibition may reduce TNF-α production in horses, a potential benefit in reducing inflammation and endotoxin-induced damage in horses." @default.
• W2955194530 created "2019-07-12" @default.
• W2955194530 creator A5002009004 @default.
• W2955194530 creator A5004614735 @default.
• W2955194530 creator A5046079930 @default.
• W2955194530 creator A5046788005 @default.
• W2955194530 creator A5056302781 @default.
• W2955194530 creator A5063764574 @default.
• W2955194530 date "2019-07-01" @default.
• W2955194530 modified "2023-09-23" @default.
• W2955194530 title "In vitro effects of poly(ADP-ribose) polymerase inhibitors on the production of tumor necrosis factor-α by interferon- γ – and lipopolysaccharide-stimulated peripheral blood mononuclear cells of horses" @default.
• W2955194530 cites W1796447585 @default.
• W2955194530 cites W1963711485 @default.
• W2955194530 cites W1968458167 @default.
• W2955194530 cites W1976805974 @default.
• W2955194530 cites W1990946891 @default.
• W2955194530 cites W1992674106 @default.
• W2955194530 cites W2005749687 @default.
• W2955194530 cites W2007594761 @default.
• W2955194530 cites W2009681400 @default.
• W2955194530 cites W2012801665 @default.
• W2955194530 cites W2014150894 @default.
• W2955194530 cites W2015705072 @default.
• W2955194530 cites W2026922977 @default.
• W2955194530 cites W2037820827 @default.
• W2955194530 cites W2039191003 @default.
• W2955194530 cites W2042423690 @default.
• W2955194530 cites W2058174439 @default.
• W2955194530 cites W2061298493 @default.
• W2955194530 cites W2062422180 @default.
• W2955194530 cites W2076690055 @default.
• W2955194530 cites W2079971015 @default.
• W2955194530 cites W2094916265 @default.
• W2955194530 cites W2099904057 @default.
• W2955194530 cites W2106059513 @default.
• W2955194530 cites W2118922694 @default.
• W2955194530 cites W2147521003 @default.
• W2955194530 cites W2159922156 @default.
• W2955194530 cites W2163846356 @default.
• W2955194530 cites W2325021350 @default.
• W2955194530 cites W2793920504 @default.
• W2955194530 doi "https://doi.org/10.2460/ajvr.80.7.663" @default.
• W2955194530 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31246122" @default.
• W2955194530 hasPublicationYear "2019" @default.
• W2955194530 type Work @default.
• W2955194530 sameAs 2955194530 @default.
• W2955194530 citedByCount "2" @default.
• W2955194530 countsByYear W29551945302020 @default.
• W2955194530 countsByYear W29551945302023 @default.
• W2955194530 crossrefType "journal-article" @default.
• W2955194530 hasAuthorship W2955194530A5002009004 @default.
• W2955194530 hasAuthorship W2955194530A5004614735 @default.
• W2955194530 hasAuthorship W2955194530A5046079930 @default.
• W2955194530 hasAuthorship W2955194530A5046788005 @default.
• W2955194530 hasAuthorship W2955194530A5056302781 @default.
• W2955194530 hasAuthorship W2955194530A5063764574 @default.
• W2955194530 hasConcept C126322002 @default.
• W2955194530 hasConcept C137061746 @default.
• W2955194530 hasConcept C1621761 @default.
• W2955194530 hasConcept C16685009 @default.
• W2955194530 hasConcept C17991360 @default.
• W2955194530 hasConcept C185592680 @default.
• W2955194530 hasConcept C202751555 @default.
• W2955194530 hasConcept C203014093 @default.
• W2955194530 hasConcept C24998067 @default.
• W2955194530 hasConcept C2778690821 @default.
• W2955194530 hasConcept C2778754761 @default.
• W2955194530 hasConcept C55493867 @default.
• W2955194530 hasConcept C71924100 @default.
• W2955194530 hasConcept C98274493 @default.
• W2955194530 hasConceptScore W2955194530C126322002 @default.
• W2955194530 hasConceptScore W2955194530C137061746 @default.
• W2955194530 hasConceptScore W2955194530C1621761 @default.
• W2955194530 hasConceptScore W2955194530C16685009 @default.
• W2955194530 hasConceptScore W2955194530C17991360 @default.
• W2955194530 hasConceptScore W2955194530C185592680 @default.
• W2955194530 hasConceptScore W2955194530C202751555 @default.
• W2955194530 hasConceptScore W2955194530C203014093 @default.
• W2955194530 hasConceptScore W2955194530C24998067 @default.
• W2955194530 hasConceptScore W2955194530C2778690821 @default.
• W2955194530 hasConceptScore W2955194530C2778754761 @default.
• W2955194530 hasConceptScore W2955194530C55493867 @default.
• W2955194530 hasConceptScore W2955194530C71924100 @default.
• W2955194530 hasConceptScore W2955194530C98274493 @default.
• W2955194530 hasIssue "7" @default.
• W2955194530 hasLocation W29551945301 @default.
• W2955194530 hasLocation W29551945302 @default.
• W2955194530 hasOpenAccess W2955194530 @default.
• W2955194530 hasPrimaryLocation W29551945301 @default.
• W2955194530 hasRelatedWork W2029372981 @default.
• W2955194530 hasRelatedWork W2047541857 @default.
• W2955194530 hasRelatedWork W2053564834 @default.
• W2955194530 hasRelatedWork W2090281136 @default.
• W2955194530 hasRelatedWork W2094027618 @default.
• W2955194530 hasRelatedWork W2103460214 @default.
• W2955194530 hasRelatedWork W2164140486 @default.
• W2955194530 hasRelatedWork W2385563803 @default.
• W2955194530 hasRelatedWork W2413218099 @default.

• next